還沒(méi)有賬號(hào)立即注冊(cè)
登錄即代表您已同意《leyu·樂(lè)魚(yú)(中國(guó))體育官方網(wǎng)站隱私政策》
登錄即代表您已同意《leyu·樂(lè)魚(yú)(中國(guó))體育官方網(wǎng)站隱私政策》
已有賬號(hào)登錄賬號(hào)
Fosun Pharmaceutical ERP Project
Shanghai Fosun Pharmaceutical (Group) Co., Ltd
Fosun Pharmaceutical, stock code: 600196.SH, 02196.HK) was established in 1994 and is a leading healthcare industry group in China. The business covers the entire pharmaceutical and health industry chain, including drug manufacturing and research and development, medical services, medical devices and diagnosis, pharmaceutical distribution and retail. Among them, drug manufacturing and research and development are the core, and medical services are the development focus.
Fosun Pharmaceutical Group regards innovation and research and development as the core driving factor for enterprise development, and has established efficient chemical innovative drug platforms, biopharmaceutical platforms, high-value generic drug platforms, and cellular immune platforms in China, the United States, India, and other places. Fosun Pharmaceutical Group's research and development continue to focus on the treatment fields of anti-tumor, cardiovascular system, central nervous system, blood system, metabolic and digestive system, and anti infection, and its main products occupy leading positions in their respective market segments.
